Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP...
-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 31, 2024 4:05pm
New Press Release - Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement
Calgary, Alberta--(Newsfile Corp. - October 31, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed its first tranche of the private placement of units ("Units"), as announced on October 11, 2024, for gross proceeds of ...
read article.
(30)
•••
cmarketinsights
X
View Profile
View Bullboard History
Post by
cmarketinsights
on Oct 22, 2024 2:22pm
Hemostemix led last week’s top performers with a 50% gain
Hemostemix led last week’s top performers with a 50% gain. As highlighted last week, HEM is actively pursuing a $4M equity financing. The company is making significant strides with
...more
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(30)
•••
cmarketinsights
X
View Profile
View Bullboard History
Post by
cmarketinsights
on Oct 16, 2024 6:53pm
Hemostemix is pursuing a $4M equity financing
Hemostemix is pursuing a $4M equity financing to further develop its ACP-01 product, which targets patients with critical limb ischemia and ischemic heart disease. This compassionate-use initiative
...more
(33)
•••
valiantaffair
X
View Profile
View Bullboard History
Post by
valiantaffair
on Oct 14, 2024 12:12pm
Cytolmmune
Not Hemostemix wesite. Im talking about Cytolmmunes website.
(1)
•••
cndinvest
X
View Profile
View Bullboard History
Comment by
cndinvest
on Oct 12, 2024 12:18pm
RE:Cytolmmune
There are 6 Press Releases during 2024 posted to their website: https://hemostemix.com/news-press-releases/
(33)
•••
valiantaffair
X
View Profile
View Bullboard History
Post by
valiantaffair
on Oct 09, 2024 10:02pm
Cytolmmune
Their website has not been updated since 2023. I think this company is done. No deal for Hemostemix. Whats next Tom back to Quebec huh. LOL what a joke.
(77)
•••
sdhaka
X
View Profile
View Bullboard History
Post by
sdhaka
on Jul 16, 2024 4:33pm
Hemostemix went up 22% wow as of july 15
Hemostemix went up 22% wow as of july 15. Can this be linked to their recent announcement relating to trademark granted by Switzerland and Interest Payment? I follow this weekly commentary
...more
(3)
•••
martel
X
View Profile
View Bullboard History
Post by
martel
on Jul 15, 2024 11:41am
Hemostemix: Pioneering Autologous Cell Therapies
Hemostemix ($HEM) leverages its advanced technology platform to develop autologous cell therapies, focusing on treatments for vascular diseases. With a 52-week range of $0.175 to $0.035, the company
...more
(77)
•••
sdhaka
X
View Profile
View Bullboard History
Post by
sdhaka
on Jun 04, 2024 2:35pm
Hemostemix Announces Partnership and Funding
Hemostemix Announces Partnership and Funding for ACP-01 Manufacturing Hemostemix Inc. (HEM) announced a strategic manufacturing partnership with CytoImmune Therapeutics, a private company
...more
(4)
•••
JocetooBad
X
View Profile
View Bullboard History
Comment by
JocetooBad
on Apr 30, 2024 3:43pm
RE:Hemostemix's Share Growth: A Sign of Therapeutic Impact
If I understand your post well, you're saying that a 77% drop in share price is highlighting the positive impact + potential of this company? I'm not following you. The drop in share price is
...more
(18)
•••
lelianicruz
X
View Profile
View Bullboard History
Post by
lelianicruz
on Apr 25, 2024 10:34am
Hemostemix's Share Growth: A Sign of Therapeutic Impact
Hemostemix's share price has shown a dynamic 52-week high/low range of $0.175 to $0.04. This fluctuation not only underscores the company's growth potential but also highlights the
...more
(4)
•••
JocetooBad
X
View Profile
View Bullboard History
Comment by
JocetooBad
on Feb 16, 2024 11:54am
RE:Ah, what will the New Year bring?
Dude, I'm in the same boat. Will a government grant save the day on the very last minute? Indeed 2024 will tell.
(44)
•••
Dudeforever
X
View Profile
View Bullboard History
Post by
Dudeforever
on Dec 07, 2023 4:52pm
Ah, what will the New Year bring?
2024 will either be HEM's last year, or else one of their many claims actually proves to have substance. Thomas has drained his cup of credibility. Raising money is going to be almost
...more
(1)
•••
Budaman
X
View Profile
View Bullboard History
Comment by
Budaman
on Oct 31, 2023 7:41pm
RE:$HEM experience is very bad
Same person, multiple new accounts, and all of them full of negativity, designed to try and get people to sell. I was waiting for the wanna be trolls to reappear with this stock, and now here
...more
(0)
•••
Gefele1424
X
View Profile
View Bullboard History
Post by
Gefele1424
on Oct 31, 2023 11:35am
$HEM experience is very bad
The company's financial statements show declining revenue; the company is not keeping up with industry trends. In my experience, this company is totally scammy.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >